Drug Side Effects
Search
GASTRITIS HYPERTROPHIC
GASTRITIS HYPERTROPHIC
was reported 41 times
GASTRITIS HYPERTROPHIC is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Claudin 18.2-directed Cytolytic Antibody [EPC]
1
0.0007
1
Ergot Derivative [EPC]
1
0.0002
2
Phosphodiesterase 5 Inhibitor [EPC]
23
0.0002
3
Prostacycline Vasodilator [EPC]
16
0.0001
4
Chloride Channel Activator [EPC]
1
0.0001
5
Endothelin Receptor Antagonist [EPC]
13
0.0001
6
Soluble Guanylate Cyclase Stimulator [EPC]
2
0.0001
7
Provitamin D2 Compound [EPC]
1
0.0000
8
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
9
Interleukin-23 Antagonist [EPC]
1
0.0000
10
P2Y12 Platelet Inhibitor [EPC]
1
0.0000
11
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
12
Angiotensin Converting Enzyme Inhibitor [EPC]
1
0.0000
13
Alkylating Drug [EPC]
1
0.0000
14
Platinum-based Drug [EPC]
1
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
16
Proton Pump Inhibitor [EPC]
2
0.0000
17
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
18
Loop Diuretic [EPC]
1
0.0000
19
Platelet Aggregation Inhibitor [EPC]
1
0.0000
20
Corticosteroid [EPC]
2
0.0000
21
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000